Skip to main content

Peer Review reports

From: ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC

Original Submission
17 Nov 2008 Submitted Original manuscript
6 Jan 2009 Reviewed Reviewer Report - Frank Giles
20 Jan 2009 Reviewed Reviewer Report - Tadeusz Robak
6 Feb 2009 Author responded Author comments - Luke Stockwin
Resubmission - Version 2
6 Feb 2009 Submitted Manuscript version 2
13 Feb 2009 Author responded Author comments - Luke Stockwin
Resubmission - Version 3
13 Feb 2009 Submitted Manuscript version 3
Publishing
20 Feb 2009 Editorially accepted
20 Feb 2009 Article published 10.1186/1471-2407-9-63

You can find further information about peer review here.

Back to article page